View Future GrowthCell Point (India) 過去の業績過去 基準チェック /16Cell Point (India)の収益は年間平均-17.4%の割合で減少していますが、 Specialty Retail業界の収益は年間 増加しています。収益は年間31.3% 7.8%割合で 増加しています。 Cell Point (India)の自己資本利益率は0.09%であり、純利益率は0.02%です。主要情報-17.40%収益成長率-23.95%EPS成長率Specialty Retail 業界の成長27.43%収益成長率7.84%株主資本利益率0.085%ネット・マージン0.017%前回の決算情報31 Mar 2026最近の業績更新Reported Earnings • May 28Full year 2026 earnings released: EPS: ₹0.034 (vs ₹1.21 in FY 2025)Full year 2026 results: EPS: ₹0.034 (down from ₹1.21 in FY 2025). Revenue: ₹3.69b (up 14% from FY 2025). Net income: ₹635.0k (down 97% from FY 2025). Profit margin: 0% (down from 0.7% in FY 2025). The decrease in margin was driven by higher expenses.お知らせ • May 22Cell Point (India) Limited to Report Second Half, 2026 Results on May 27, 2026Cell Point (India) Limited announced that they will report second half, 2026 results on May 27, 2026Reported Earnings • Nov 18First half 2026 earnings released: EPS: ₹0.10 (vs ₹0.12 in 1H 2025)First half 2026 results: EPS: ₹0.10 (down from ₹0.12 in 1H 2025). Revenue: ₹1.77b (up 15% from 1H 2025). Net income: ₹1.91m (down 15% from 1H 2025). Profit margin: 0.1% (in line with 1H 2025).お知らせ • Nov 07Cell Point (India) Limited to Report First Half, 2026 Results on Nov 12, 2025Cell Point (India) Limited announced that they will report first half, 2026 results on Nov 12, 2025Reported Earnings • Jul 22Full year 2023 earnings released: EPS: ₹4.93 (vs ₹1.21 in FY 2022)Full year 2023 results: EPS: ₹4.93 (up from ₹1.21 in FY 2022). Revenue: ₹2.96b (up 9.8% from FY 2022). Net income: ₹67.3m (up 309% from FY 2022). Profit margin: 2.3% (up from 0.6% in FY 2022). The increase in margin was driven by higher revenue.すべての更新を表示Recent updatesReported Earnings • May 28Full year 2026 earnings released: EPS: ₹0.034 (vs ₹1.21 in FY 2025)Full year 2026 results: EPS: ₹0.034 (down from ₹1.21 in FY 2025). Revenue: ₹3.69b (up 14% from FY 2025). Net income: ₹635.0k (down 97% from FY 2025). Profit margin: 0% (down from 0.7% in FY 2025). The decrease in margin was driven by higher expenses.お知らせ • May 22Cell Point (India) Limited to Report Second Half, 2026 Results on May 27, 2026Cell Point (India) Limited announced that they will report second half, 2026 results on May 27, 2026Valuation Update With 7 Day Price Move • Apr 09Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹15.60, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 19x in the Specialty Retail industry in India. Total loss to shareholders of 13% over the past year.New Risk • Apr 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Earnings have declined by 7.6% per year over the past 5 years. Market cap is less than US$10m (₹254.1m market cap, or US$2.72m). Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Large one-off items impacting financial results.Reported Earnings • Nov 18First half 2026 earnings released: EPS: ₹0.10 (vs ₹0.12 in 1H 2025)First half 2026 results: EPS: ₹0.10 (down from ₹0.12 in 1H 2025). Revenue: ₹1.77b (up 15% from 1H 2025). Net income: ₹1.91m (down 15% from 1H 2025). Profit margin: 0.1% (in line with 1H 2025).New Risk • Nov 13New major risk - Revenue and earnings growthEarnings have declined by 7.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.0x net interest cover). Earnings have declined by 7.6% per year over the past 5 years. High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₹344.7m market cap, or US$3.89m).お知らせ • Nov 07Cell Point (India) Limited to Report First Half, 2026 Results on Nov 12, 2025Cell Point (India) Limited announced that they will report first half, 2026 results on Nov 12, 2025お知らせ • Sep 03Cell Point (India) Limited, Annual General Meeting, Sep 27, 2025Cell Point (India) Limited, Annual General Meeting, Sep 27, 2025, at 11:30 Indian Standard Time. Location: 30-12-139, first floor, room no.5&6, ramas arcade, dabagardens, visakhapatnam, ap - 530020, India分析記事 • Aug 20Cell Point (India) (NSE:CELLPOINT) Has No Shortage Of DebtNSEI:CELLPOINT 1 Year Share Price vs Fair Value Explore Cell Point (India)'s Fair Values from the Community and select...New Risk • Aug 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.8x net interest cover). Market cap is less than US$10m (₹331.7m market cap, or US$3.79m). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.7% average weekly change). Large one-off items impacting financial results.New Risk • Jun 25New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 502% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Market cap is less than US$10m (₹347.6m market cap, or US$4.05m). Minor Risk Large one-off items impacting financial results.New Risk • May 21New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Market cap is less than US$10m (₹330.7m market cap, or US$3.86m). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (0.07% net profit margin).分析記事 • Jan 29These 4 Measures Indicate That Cell Point (India) (NSE:CELLPOINT) Is Using Debt In A Risky WayLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...お知らせ • Sep 27Cell Point (India) Limited Declares Final Dividend for the Financial Year Ended March 31, 2024Cell Point (India) Limited announced at the AGM held on September 27, 2024, approved declare final dividend on equity shares at the rate of 2.5% [i.e. INR 0.25/- (Rupees Twenty Five paisa only) per Equity Share of Face Value of INR 10/- (Rupees Twenty Five paisa only) for the financial year ended March 31, 2024.お知らせ • Sep 13Cell Point (India) Limited, Annual General Meeting, Sep 27, 2024Cell Point (India) Limited, Annual General Meeting, Sep 27, 2024, at 11:30 Indian Standard Time. Location: 30-12-139, first floor, room no.5&6, ramas arcade, dabagardens, visakhapatnam, ap-530009, IndiaNew Risk • May 31New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (35% accrual ratio). Market cap is less than US$10m (₹644.7m market cap, or US$7.74m). Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹37.30, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 48x in the Specialty Retail industry in India.分析記事 • Mar 13These 4 Measures Indicate That Cell Point (India) (NSE:CELLPOINT) Is Using Debt ExtensivelySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...New Risk • Nov 22New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹820.3m (US$9.85m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (35% accrual ratio). Market cap is less than US$10m (₹820.3m market cap, or US$9.85m).New Risk • Nov 20New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 35% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (35% accrual ratio). Minor Risk Market cap is less than US$100m (₹833.4m market cap, or US$10.0m).お知らせ • Sep 08Cell Point (India) Limited, Annual General Meeting, Sep 29, 2023Cell Point (India) Limited, Annual General Meeting, Sep 29, 2023, at 11:30 Indian Standard Time. Location: Door No 30-15-139/F/5, 6 Ward No 27, Ram's Arcade Opposite Visakha Medical Centre, Dabagardens Visakapatnam Andhra Pradesh IndiaValuation Update With 7 Day Price Move • Aug 03Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹55.55, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 38x in the Specialty Retail industry in India.Reported Earnings • Jul 22Full year 2023 earnings released: EPS: ₹4.93 (vs ₹1.21 in FY 2022)Full year 2023 results: EPS: ₹4.93 (up from ₹1.21 in FY 2022). Revenue: ₹2.96b (up 9.8% from FY 2022). Net income: ₹67.3m (up 309% from FY 2022). Profit margin: 2.3% (up from 0.6% in FY 2022). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Jul 14Investor sentiment deteriorates as stock falls 32%After last week's 32% share price decline to ₹49.05, the stock trades at a trailing P/E ratio of 55.7x. Average trailing P/E is 38x in the Specialty Retail industry in India.Board Change • Jun 29Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Ananda Ravada was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.収支内訳Cell Point (India) の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史NSEI:CELLPOINT 収益、費用、利益 ( )INR Millions日付収益収益G+A経費研究開発費31 Mar 263,6791118031 Dec 253,58011175030 Sep 253,48122232030 Jun 253,36422232031 Mar 253,24723233031 Dec 243,20912227030 Sep 243,1702222030 Jun 243,19110220031 Mar 243,21217218031 Dec 233,13031209030 Sep 233,04845199030 Jun 233,00256196031 Mar 232,95767194031 Mar 222,69216189031 Mar 212,2307155031 Mar 202,776161920質の高い収益: CELLPOINTは 高品質の収益 を持っています。利益率の向上: CELLPOINTの現在の純利益率 (0.02%)は、昨年(0.7%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: CELLPOINTの収益は過去 5 年間で年間17.4%減少しました。成長の加速: CELLPOINTは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: CELLPOINTは過去 1 年間で収益成長率がマイナス ( -97.2% ) となったため、 Specialty Retail業界平均 ( 33.6% ) と比較することが困難です。株主資本利益率高いROE: CELLPOINTの 自己資本利益率 ( 0.09% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YRetail 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/30 00:11終値2026/06/25 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Cell Point (India) Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • May 28Full year 2026 earnings released: EPS: ₹0.034 (vs ₹1.21 in FY 2025)Full year 2026 results: EPS: ₹0.034 (down from ₹1.21 in FY 2025). Revenue: ₹3.69b (up 14% from FY 2025). Net income: ₹635.0k (down 97% from FY 2025). Profit margin: 0% (down from 0.7% in FY 2025). The decrease in margin was driven by higher expenses.
お知らせ • May 22Cell Point (India) Limited to Report Second Half, 2026 Results on May 27, 2026Cell Point (India) Limited announced that they will report second half, 2026 results on May 27, 2026
Reported Earnings • Nov 18First half 2026 earnings released: EPS: ₹0.10 (vs ₹0.12 in 1H 2025)First half 2026 results: EPS: ₹0.10 (down from ₹0.12 in 1H 2025). Revenue: ₹1.77b (up 15% from 1H 2025). Net income: ₹1.91m (down 15% from 1H 2025). Profit margin: 0.1% (in line with 1H 2025).
お知らせ • Nov 07Cell Point (India) Limited to Report First Half, 2026 Results on Nov 12, 2025Cell Point (India) Limited announced that they will report first half, 2026 results on Nov 12, 2025
Reported Earnings • Jul 22Full year 2023 earnings released: EPS: ₹4.93 (vs ₹1.21 in FY 2022)Full year 2023 results: EPS: ₹4.93 (up from ₹1.21 in FY 2022). Revenue: ₹2.96b (up 9.8% from FY 2022). Net income: ₹67.3m (up 309% from FY 2022). Profit margin: 2.3% (up from 0.6% in FY 2022). The increase in margin was driven by higher revenue.
Reported Earnings • May 28Full year 2026 earnings released: EPS: ₹0.034 (vs ₹1.21 in FY 2025)Full year 2026 results: EPS: ₹0.034 (down from ₹1.21 in FY 2025). Revenue: ₹3.69b (up 14% from FY 2025). Net income: ₹635.0k (down 97% from FY 2025). Profit margin: 0% (down from 0.7% in FY 2025). The decrease in margin was driven by higher expenses.
お知らせ • May 22Cell Point (India) Limited to Report Second Half, 2026 Results on May 27, 2026Cell Point (India) Limited announced that they will report second half, 2026 results on May 27, 2026
Valuation Update With 7 Day Price Move • Apr 09Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹15.60, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 19x in the Specialty Retail industry in India. Total loss to shareholders of 13% over the past year.
New Risk • Apr 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Earnings have declined by 7.6% per year over the past 5 years. Market cap is less than US$10m (₹254.1m market cap, or US$2.72m). Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Large one-off items impacting financial results.
Reported Earnings • Nov 18First half 2026 earnings released: EPS: ₹0.10 (vs ₹0.12 in 1H 2025)First half 2026 results: EPS: ₹0.10 (down from ₹0.12 in 1H 2025). Revenue: ₹1.77b (up 15% from 1H 2025). Net income: ₹1.91m (down 15% from 1H 2025). Profit margin: 0.1% (in line with 1H 2025).
New Risk • Nov 13New major risk - Revenue and earnings growthEarnings have declined by 7.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.0x net interest cover). Earnings have declined by 7.6% per year over the past 5 years. High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₹344.7m market cap, or US$3.89m).
お知らせ • Nov 07Cell Point (India) Limited to Report First Half, 2026 Results on Nov 12, 2025Cell Point (India) Limited announced that they will report first half, 2026 results on Nov 12, 2025
お知らせ • Sep 03Cell Point (India) Limited, Annual General Meeting, Sep 27, 2025Cell Point (India) Limited, Annual General Meeting, Sep 27, 2025, at 11:30 Indian Standard Time. Location: 30-12-139, first floor, room no.5&6, ramas arcade, dabagardens, visakhapatnam, ap - 530020, India
分析記事 • Aug 20Cell Point (India) (NSE:CELLPOINT) Has No Shortage Of DebtNSEI:CELLPOINT 1 Year Share Price vs Fair Value Explore Cell Point (India)'s Fair Values from the Community and select...
New Risk • Aug 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.8x net interest cover). Market cap is less than US$10m (₹331.7m market cap, or US$3.79m). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.7% average weekly change). Large one-off items impacting financial results.
New Risk • Jun 25New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 502% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Market cap is less than US$10m (₹347.6m market cap, or US$4.05m). Minor Risk Large one-off items impacting financial results.
New Risk • May 21New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Market cap is less than US$10m (₹330.7m market cap, or US$3.86m). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (0.07% net profit margin).
分析記事 • Jan 29These 4 Measures Indicate That Cell Point (India) (NSE:CELLPOINT) Is Using Debt In A Risky WayLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
お知らせ • Sep 27Cell Point (India) Limited Declares Final Dividend for the Financial Year Ended March 31, 2024Cell Point (India) Limited announced at the AGM held on September 27, 2024, approved declare final dividend on equity shares at the rate of 2.5% [i.e. INR 0.25/- (Rupees Twenty Five paisa only) per Equity Share of Face Value of INR 10/- (Rupees Twenty Five paisa only) for the financial year ended March 31, 2024.
お知らせ • Sep 13Cell Point (India) Limited, Annual General Meeting, Sep 27, 2024Cell Point (India) Limited, Annual General Meeting, Sep 27, 2024, at 11:30 Indian Standard Time. Location: 30-12-139, first floor, room no.5&6, ramas arcade, dabagardens, visakhapatnam, ap-530009, India
New Risk • May 31New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (35% accrual ratio). Market cap is less than US$10m (₹644.7m market cap, or US$7.74m). Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).
Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹37.30, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 48x in the Specialty Retail industry in India.
分析記事 • Mar 13These 4 Measures Indicate That Cell Point (India) (NSE:CELLPOINT) Is Using Debt ExtensivelySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
New Risk • Nov 22New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹820.3m (US$9.85m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (35% accrual ratio). Market cap is less than US$10m (₹820.3m market cap, or US$9.85m).
New Risk • Nov 20New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 35% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (35% accrual ratio). Minor Risk Market cap is less than US$100m (₹833.4m market cap, or US$10.0m).
お知らせ • Sep 08Cell Point (India) Limited, Annual General Meeting, Sep 29, 2023Cell Point (India) Limited, Annual General Meeting, Sep 29, 2023, at 11:30 Indian Standard Time. Location: Door No 30-15-139/F/5, 6 Ward No 27, Ram's Arcade Opposite Visakha Medical Centre, Dabagardens Visakapatnam Andhra Pradesh India
Valuation Update With 7 Day Price Move • Aug 03Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹55.55, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 38x in the Specialty Retail industry in India.
Reported Earnings • Jul 22Full year 2023 earnings released: EPS: ₹4.93 (vs ₹1.21 in FY 2022)Full year 2023 results: EPS: ₹4.93 (up from ₹1.21 in FY 2022). Revenue: ₹2.96b (up 9.8% from FY 2022). Net income: ₹67.3m (up 309% from FY 2022). Profit margin: 2.3% (up from 0.6% in FY 2022). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Jul 14Investor sentiment deteriorates as stock falls 32%After last week's 32% share price decline to ₹49.05, the stock trades at a trailing P/E ratio of 55.7x. Average trailing P/E is 38x in the Specialty Retail industry in India.
Board Change • Jun 29Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Ananda Ravada was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.